<DOC>
	<DOC>NCT02484898</DOC>
	<brief_summary>The purpose of the Medtronic SEEQ™ Performance study is to build further evidence on the clinical and economic benefit of the Medtronic market-released SEEQ™ Mobile Cardiac Telemetry System/External Cardiac Monitor System (MCT/ECM).</brief_summary>
	<brief_title>SEEQ™ Performance Study</brief_title>
	<detailed_description />
	<criteria>Patient is indicated for a SEEQ™ MCT/ECM System for approved indications Patient is 18 years of age or older Patient is willing and able to provide consent and authorize the use and disclosure of health information Patient is willing and able to comply with the protocol Patient has known allergy and/or hypersensitivity to adhesives or hydrogel. Patient has suspected potential lifethreatening arrhythmias, or requires insubject/inhospital monitoring. Patient will undergo a medical procedure that would preclude full participate during the prescribed duration of the SEEQ™ Patient has an implanted cardiac device, (e.g., pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>